CRH (CRH) Stock Forecast, Price Target & Predictions
CRH Stock Forecast
CRH stock forecast is as follows: an average price target of $99.00 (represents a 10.90% upside from CRH’s last price of $89.27) and a rating consensus of 'Buy', based on 10 wall street analysts offering a 1-year stock forecast.
CRH Price Target
The average price target for CRH (CRH) is $99.00 based on 1-year price targets from 10 Wall Street analysts in the past 3 months, with a price target range of $110.00 to $88.00. This represents a potential 10.90% upside from CRH's last price of $89.27.
CRH Analyst Ratings
According to 10 Wall Street analysts, CRH's rating consensus is 'Buy'. The analyst rating breakdown for CRH stock is 0 'Strong Buy' (0.00%), 7 'Buy' (70.00%), 2 'Hold' (20.00%), 1 'Sell' (10.00%), and 0 'Strong Sell' (0.00%).
CRH Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 09, 2024 | Keith Hughes | Truist Financial | $110.00 | $82.79 | 32.87% | 23.22% |
| Jul 09, 2024 | Cedar Ekblom | Morgan Stanley | $88.00 | $74.23 | 18.55% | -1.42% |
| May 13, 2024 | Keith Hughes | Truist Financial | $100.00 | $83.44 | 19.85% | 12.02% |
| Dec 14, 2023 | Keith Hughes | Truist Financial | $81.00 | $67.50 | 20.00% | -9.26% |
The latest CRH stock forecast, released on Aug 09, 2024 by Keith Hughes from Truist Financial, set a price target of $110.00, which represents a 32.87% increase from the stock price at the time of the forecast ($82.79), and a 23.22% increase from CRH last price ($89.27).
CRH Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 4 |
| Avg Price Target | - | $99.00 | $94.75 |
| Last Closing Price | $89.27 | $89.27 | $89.27 |
| Upside/Downside | -100.00% | 10.90% | 6.14% |
In the current month, the average price target of CRH stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CRH's last price of $89.27. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 13, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Jul 09, 2024 | Morgan Stanley | - | Overweight | Upgrade |
| Jun 17, 2024 | Stephens | - | Overweight | Initialise |
| May 14, 2024 | RBC Capital | - | Outperform | Initialise |
| Apr 05, 2024 | Citigroup | Buy | Buy | Hold |
| Feb 06, 2023 | Citigroup | Buy | Buy | Hold |
| Feb 06, 2023 | Telsey Advisory | - | Market Perform | Downgrade |
| Jan 03, 2023 | Redburn Partners | - | Buy | Upgrade |
| Dec 12, 2022 | Goldman Sachs | - | Sell | Downgrade |
| Nov 18, 2022 | Wedbush | - | Neutral | Downgrade |
CRH's last stock rating was published by Deutsche Bank on Sep 13, 2024. The company gave CRH a "Buy" rating, the same as its previous rate.
CRH Financial Forecast
CRH Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $9.65B | $11.20B | $10.26B | $6.93B | $9.19B | $10.63B | $10.18B | $6.39B | $8.24B | $8.93B | $17.07B | $14.96B | $16.40B | $13.45B | $15.21B | $17.25B | $14.73B |
| High Forecast | $9.89B | $11.49B | $10.51B | $7.11B | $9.42B | $10.91B | $10.44B | $6.55B | $8.43B | $9.16B | $17.50B | $15.33B | $16.81B | $13.80B | $15.60B | $17.69B | $15.10B |
| Low Forecast | $9.54B | $11.08B | $10.14B | $6.86B | $9.09B | $10.40B | $10.07B | $6.31B | $8.05B | $8.83B | $16.88B | $14.79B | $16.22B | $13.23B | $14.95B | $16.96B | $14.48B |
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 7 | 15 | 1 | - | - | - | - | - | - | - |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CRH's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CRH's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
CRH EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 7 | 15 | 1 | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.59B | $1.85B | $1.69B | $1.14B | $1.51B | $1.75B | $1.68B | $1.05B | $1.36B | $1.47B | $2.81B | $2.46B | $2.70B | $2.22B | $2.50B | $2.84B | $2.43B |
| High Forecast | $1.63B | $1.89B | $1.73B | $1.17B | $1.55B | $1.80B | $1.72B | $1.08B | $1.39B | $1.51B | $2.88B | $2.53B | $2.77B | $2.27B | $2.57B | $2.91B | $2.49B |
| Low Forecast | $1.57B | $1.82B | $1.67B | $1.13B | $1.50B | $1.71B | $1.66B | $1.04B | $1.32B | $1.45B | $2.78B | $2.44B | $2.67B | $2.18B | $2.46B | $2.79B | $2.38B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
undefined analysts predict CRH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than CRH's previous annual EBITDA (undefined) of $NaN.
CRH Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 7 | 15 | 1 | - | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.09B | $1.66B | $1.46B | $1.52M | $971.44M | $1.45B | $1.23B | $-65.44M | $1.87B | $956.14M | $578.59M | $578.59M | $1.29B | $599.26M | $1.22B | $1.22B | $402.52M |
| High Forecast | $1.13B | $1.71B | $1.51B | $1.57M | $1.00B | $1.50B | $1.27B | $-64.49M | $1.93B | $987.50M | $597.57M | $597.57M | $1.34B | $619.09M | $1.26B | $1.26B | $415.84M |
| Low Forecast | $1.08B | $1.64B | $1.44B | $1.49M | $957.36M | $1.41B | $1.21B | $-67.58M | $1.84B | $942.29M | $570.21M | $570.21M | $1.28B | $586.12M | $1.20B | $1.19B | $393.70M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CRH's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CRH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
CRH SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 7 | 15 | 1 | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $2.16B | $2.51B | $2.30B | $1.55B | $2.06B | $2.38B | $2.28B | $1.43B | $1.85B | $2.00B | $3.82B | $3.35B | $3.67B | $3.01B | $3.41B | $3.86B | $3.30B |
| High Forecast | $2.22B | $2.57B | $2.36B | $1.59B | $2.11B | $2.44B | $2.34B | $1.47B | $1.89B | $2.05B | $3.92B | $3.43B | $3.77B | $3.09B | $3.49B | $3.96B | $3.38B |
| Low Forecast | $2.14B | $2.48B | $2.27B | $1.54B | $2.04B | $2.33B | $2.25B | $1.41B | $1.80B | $1.98B | $3.78B | $3.31B | $3.63B | $2.96B | $3.35B | $3.80B | $3.24B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CRH's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CRH last annual SG&A of $NaN (undefined).
CRH EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 7 | 15 | 1 | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Avg Forecast | $1.59 | $2.41 | $2.12 | - | $1.41 | $2.11 | $1.79 | $-0.10 | $2.71 | $1.39 | $0.84 | $0.84 | $1.88 | $0.87 | $1.77 | $1.77 | $0.58 |
| High Forecast | $1.64 | $2.49 | $2.19 | - | $1.46 | $2.18 | $1.85 | $-0.09 | $2.80 | $1.43 | $0.87 | $0.87 | $1.94 | $0.90 | $1.83 | $1.83 | $0.60 |
| Low Forecast | $1.56 | $2.38 | $2.09 | - | $1.39 | $2.04 | $1.76 | $-0.10 | $2.68 | $1.37 | $0.83 | $0.83 | $1.85 | $0.85 | $1.74 | $1.73 | $0.57 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
According to undefined Wall Street analysts, CRH's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CRH previous annual EPS of $NaN (undefined).
CRH Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CX | CEMEX | $6.13 | $8.58 | 39.97% | Buy |
| SUM | Summit Materials | $39.10 | $46.00 | 17.65% | Buy |
| CRH | CRH | $89.27 | $99.00 | 10.90% | Buy |
| VMC | Vulcan Materials Company | $245.12 | $241.08 | -1.65% | Buy |
| MLM | Martin Marietta Materials | $534.04 | $522.77 | -2.11% | Buy |
| EXP | Eagle Materials | $280.72 | $263.22 | -6.23% | Buy |
CRH Forecast FAQ
Is CRH a good buy?
Yes, according to 10 Wall Street analysts, CRH (CRH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 70.00% of CRH's total ratings.
What is CRH's price target?
CRH (CRH) average price target is $99 with a range of $88 to $110, implying a 10.90% from its last price of $89.27. The data is based on 10 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will CRH stock go up soon?
According to Wall Street analysts' prediction for CRH stock, the company can go up by 10.90% (from the last price of $89.27 to the average price target of $99), up by 23.22% based on the highest stock price target, and down by -1.42% based on the lowest stock price target.
Can CRH stock reach $130?
CRH's average twelve months analyst stock price target of $99 does not support the claim that CRH can reach $130 in the near future.
What are CRH's analysts' financial forecasts?
CRH's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $36.38B (high $37.32B, low $35.87B), average EBITDA is $5.99B (high $6.15B, low $5.91B), average net income is $3.59B (high $3.71B, low $3.51B), average SG&A $8.15B (high $8.36B, low $8.03B), and average EPS is $5.22 (high $5.39, low $5.1). CRH's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $38.04B (high $39B, low $37.61B), average EBITDA is $6.26B (high $6.42B, low $6.19B), average net income is $4.21B (high $4.35B, low $4.15B), average SG&A $8.52B (high $8.74B, low $8.43B), and average EPS is $6.12 (high $6.32, low $6.03).
Did the CRH's actual financial results beat the analysts' financial forecasts?
Based on CRH's last annual report (Dec 2022), the company's revenue was $32.72B, which missed the average analysts forecast of $60.02B by -45.48%. Apple's EBITDA was $5.68B, missing the average prediction of $9.88B by -42.57%. The company's net income was $2.68B, missing the average estimation of $3.7B by -27.37%. Apple's SG&A was $6.98B, missing the average forecast of $13.44B by -48.04%. Lastly, the company's EPS was $3.54, missing the average prediction of $5.37 by -34.02%.